期刊
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY
卷 60, 期 2, 页码 221-224出版社
ELSEVIER TAIWAN
DOI: 10.1016/j.tjog.2020.12.004
关键词
Growth differentiation factor-15; GDM; Perinatal outcome; Oxidative stress
This study found that patients with GDM have higher levels of serum GDF-15, which is associated with disease risk. The results suggest that GDF-15 may serve as a diagnostic biomarker for GDM, but further research is needed to explore its correlation with perinatal outcomes.
Objective: Growth differentiation factor-15 (GDF-15), the new member of transforming growth factor (TGF)-beta family, is released as a response of oxidative stress, inflammation and tissue injury. We aimed to determine GDF-15 levels in patients with Gestational Diabetes Mellitus (GDM) and the relation between GDF-15 and adverse perinatal outcomes. Materials and methods:: Forty pregnant women with GDM (receiving diet and insulin therapy) and forty healthy pregnant women as control group participated in this current study. GDF-15 levels were analyzed by enzyme-linked immunosorbent assess kit. Results: The median serum GDF-15 level was measured higher in patients with GDM, and it was statistically meaningful (p: 0.000). Logistic regression analysis indicated that with the increase of GDF-15 level, the risk of GDM diseases increases as well. (P: 0.001, OR = 1.009; 95% CI = 1.003-1.014). There were no differences between GDF-15 levels and perinatal outcomes. Conclusion: We concluded that higher GDF-15 levels are related to GDM in the third trimester. The optimal GDF-15 cut-off value was measured as 326 pg/ml for the diagnosis of GDM with 70% sensitivity and 60% specificity in our study. Further studies are needed to show the significance of GDF-15 as a biomarker for the disease. ? 2021 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据